Revolving door redux: The DEA’s recently departed No. 2 returns to a Big Pharma consulting firm
WASHINGTON — Washington’s revolving door kept spinning this week as the Drug Enforcement Administration’s recently departed second-in-command returned for a new stint with the high-powered consulting firm where he previously …
